2019
DOI: 10.1016/s0618-8278(19)30400-1
|View full text |Cite
|
Sign up to set email alerts
|

THU-125-High real-world effectiveness of elbasvir/grazoprevir in PWID on opioid substitution therapy with HCV genotype 1 infection: Results from the German hepatitis C registry (DHC-R)

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles